about
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membraneCholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicitySequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy.Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.Architecture of the human PI4KIIIα lipid kinase complex.Deep and Durable Response With Combination CTLA-4 and PD-1 Blockade in Mismatch Repair (MMR)-proficient Endometrial CancerDetection of minimal residual disease using ctDNA in lung cancer: current evidence and future directionsMutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinomaAnalysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway AberrationsClinical and Immunological Implications of Frameshift Mutations in Lung CancerEarly assessment of molecular progression and response by whole-genome circulating tumor DNA in advanced solid tumors
P50
Q28116273-14B65F36-6D88-4DEF-8A11-2A55A26153FDQ36094353-C0AF7738-966F-44C0-A493-7B9FC8CBC93EQ37624426-702B7A75-C02A-45EE-AB1F-9381F79BA321Q47292249-802E8E98-44E1-48F7-8DB7-A5EB3C6544D2Q47304877-A73E0860-4BED-40CE-B70F-706B5C1BD8E7Q56887901-22DEF390-EBFE-41D4-9031-E8AEF8234631Q57185179-5F054019-D850-4F0C-9DB3-0E22A3FB5F5EQ64084665-3E92B0F3-72A4-42AD-A8C0-945DBDD5E461Q91838880-00207CEB-8A5D-4D66-B277-689FDF75AE29Q93015448-05966FB5-E25A-499C-AC13-A25D9654D2B6Q94552618-3F958B35-7A53-4D58-9468-6D31C543BFDB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael S. Oh
@ast
Michael S. Oh
@en
Michael S. Oh
@es
Michael S. Oh
@nl
Michael S. Oh
@sl
type
label
Michael S. Oh
@ast
Michael S. Oh
@en
Michael S. Oh
@es
Michael S. Oh
@nl
Michael S. Oh
@sl
prefLabel
Michael S. Oh
@ast
Michael S. Oh
@en
Michael S. Oh
@es
Michael S. Oh
@nl
Michael S. Oh
@sl
P106
P1153
55315714100
56959812400
P21
P31
P496
0000-0002-7206-771X